Depression in Pregnancy: Treat or Do Not Treat?
Volume 2 - Issue 1
Amani Mohsen*
-
Author Information
Open or Close
- Woman’s Health Center, Médecins Sans Frontières, Beirut, Lebanon
*Corresponding author:
Amani Mohsen, Woman’s Health Center, Médecins Sans Frontières, Beirut, Lebanon
Received: July 19, 2018; Published: July 25, 2018
DOI: 10.32474/DDIPIJ.2018.02.000128
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
Globally, mental health disorders are increasingly prevalent
worldwide with depression particularly contributed to the
largest percentage of global disability (7.5% of all years lived
with disability in 2015). It is more common in females than males
affecting 4 -7% of women in reproductive age group [1]. Women
with mild depression are treated with cognitive based therapy
and antidepressants are used depending on the severity of the
symptoms [2]. Utilizing antidepressants preconception and during
pregnancy was assessed in wide range of studies to evaluate the
risk of associated congenital anomalies. Ornoy et al reviewed the
association between tricyclic antidepressants (TCA) and congenital
anomalies. Early studies showed slight increase in the associated
risk however the following large studies showed no association
[2].
Mini Review|
Refernces|